Clinical Trial Update: Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System Lymphoma [NA]

View source ↗

Summary

Clinical trial update noting ongoing recruitment for a regimen of rituximab, methotrexate, and thiotepa induction followed by etoposide and cytarabine consolida…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• METHOTREXATE (METHOTREXATE)
• Rituximab (rituximab)
• TEPADINA (THIOTEPA)

Snippet

Sponsor: FengYan Jin | Conditions: Primary Central Nervous System Lymphoma (PCNSL), CNS Lymphoma Treatment | NA | Status: RECRUITING